Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension-Reference-Cited by-同舟云学术

Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension

Published:2018-07-27 Issue:1 Volume:12 Page:92-100
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Hanna Ramy M¹,Lopez Eduardo A²,Hasnain Huma¹,Selamet Umut¹,Wilson James¹,Youssef Peter N³,Akladeous Nermeen⁴,Bunnapradist Suphamai⁵,Gorin Michael B⁶

Affiliation:

1. Division of Nephrology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA

2. Division of Nephrology, Department of Medicine, Kaiser Permanente Panorama City, Panorama City, CA, USA

3. Division of Transplant Nephrology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, USA

4. Department of Preventative Medicine, Loma Linda University School of Medicine, Los Angeles, CA, USA

5. Division of Ophthalmology, Department of Surgery, Kaiser Permanente La Palma, La Palma, CA, USA

6. Retinal Disorders and Ophthalmic Genetics, Department of Ophthalmology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/12/1/92/27721392/sfy060.pdf

Reference44 articles.

1. Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study;Harshman;Lancet Oncol,2012

2. Contemporary use of bevacizumab in ovarian cancer;Miyake;Expert Opin Biol Ther,2013

3. Carboplatin and bevacizumab for recurrent malignant glioma;Mrugala;Oncol Lett,2012

4. Bevacizumab and breast cancer: a meta-analysis of first-line phase III studies and a critical reappraisal of available evidence;Rossari;J Oncol,2012

5. Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer;Soria;Ann Oncol,2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Uncovering the Role of Anoikis-Related Genes in Modulating Immune Infiltration and Pathogenesis of Diabetic Kidney Disease;Journal of Inflammation Research;2024-07

3. Effect of Intravitreal Anti-Endothelial Growth Factor Agents on Renal Function in Patients With Diabetes Mellitus;Kidney International Reports;2024-05

4. Ocular and systemic vascular endothelial growth factor ligand inhibitor use and nephrotoxicity: an update;International Urology and Nephrology;2024-03-18

5. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes;Cardiovascular Diabetology;2024-02-01